CRIS Current Research Information System

CESCON, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.156
AS - Asia 24.368
EU - Europa 16.758
AF - Africa 1.473
SA - Sud America 1.433
Continente sconosciuto - Info sul continente non disponibili 1.320
OC - Oceania 56
Totale 71.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.581
VN - Vietnam 6.920
SG - Singapore 6.326
CN - Cina 5.191
IT - Italia 3.532
GB - Regno Unito 3.091
DE - Germania 2.315
HK - Hong Kong 1.956
SE - Svezia 1.652
NL - Olanda 1.523
IN - India 1.211
FR - Francia 1.061
BR - Brasile 1.015
RU - Federazione Russa 741
BD - Bangladesh 711
UA - Ucraina 588
IE - Irlanda 564
KR - Corea 470
FI - Finlandia 431
JP - Giappone 385
CI - Costa d'Avorio 382
ZA - Sudafrica 359
CA - Canada 308
TG - Togo 271
CH - Svizzera 224
EE - Estonia 215
SC - Seychelles 197
AR - Argentina 178
PH - Filippine 172
BG - Bulgaria 159
JO - Giordania 138
TH - Thailandia 127
ID - Indonesia 123
AT - Austria 111
NG - Nigeria 110
MX - Messico 103
ES - Italia 99
BE - Belgio 94
PL - Polonia 93
IQ - Iraq 91
TR - Turchia 89
EC - Ecuador 81
PK - Pakistan 75
TW - Taiwan 68
SA - Arabia Saudita 55
AU - Australia 49
UZ - Uzbekistan 45
RO - Romania 43
IR - Iran 40
CL - Cile 37
JM - Giamaica 33
GR - Grecia 31
LT - Lituania 30
CR - Costa Rica 29
MY - Malesia 29
CO - Colombia 28
HR - Croazia 28
VE - Venezuela 26
MA - Marocco 25
PE - Perù 25
PY - Paraguay 24
EG - Egitto 23
MK - Macedonia 22
AE - Emirati Arabi Uniti 21
HN - Honduras 19
KE - Kenya 18
ET - Etiopia 16
TN - Tunisia 16
DZ - Algeria 15
DO - Repubblica Dominicana 14
NP - Nepal 14
CZ - Repubblica Ceca 13
LB - Libano 13
RS - Serbia 13
PR - Porto Rico 12
PS - Palestinian Territory 12
UY - Uruguay 12
PT - Portogallo 11
SK - Slovacchia (Repubblica Slovacca) 11
AL - Albania 10
NI - Nicaragua 9
OM - Oman 9
AZ - Azerbaigian 8
DK - Danimarca 8
GT - Guatemala 8
IL - Israele 8
PA - Panama 8
TT - Trinidad e Tobago 8
LK - Sri Lanka 7
GH - Ghana 6
HU - Ungheria 6
KH - Cambogia 6
LU - Lussemburgo 6
LY - Libia 6
NO - Norvegia 6
SV - El Salvador 6
AM - Armenia 5
BH - Bahrain 5
GP - Guadalupe 5
KZ - Kazakistan 5
Totale 70.128
Salva come PNG Salva come JPEG
Città #
Singapore 4.395
Ashburn 2.723
Southend 2.594
Fairfield 2.420
Hong Kong 1.849
Chandler 1.711
Ho Chi Minh City 1.509
San Jose 1.341
Hanoi 1.221
Woodbridge 1.146
Dong Ket 1.094
Houston 954
Wilmington 954
Seattle 934
Santa Clara 929
Hefei 881
Cambridge 782
Bologna 742
Princeton 737
Kerkrade 651
Council Bluffs 648
Ann Arbor 623
Beijing 611
Los Angeles 585
Boardman 572
Dublin 562
Frankfurt am Main 488
Dallas 487
Lauterbourg 413
New York 399
Abidjan 381
Seoul 379
Helsinki 346
Eygelshoven 338
Jacksonville 333
Tokyo 317
Milan 276
Lomé 271
Westminster 270
Nanjing 268
Munich 245
Berlin 229
Padova 229
Buffalo 225
Da Nang 224
Haiphong 218
Bern 184
São Paulo 168
Rome 161
Sofia 155
Florence 141
Jinan 141
Redondo Beach 138
Saint Petersburg 134
Guangzhou 132
San Diego 132
Amman 131
Shenyang 129
Redmond 106
Turin 101
Chicago 100
Delhi 100
Changsha 96
Shanghai 96
Dearborn 93
Phoenix 92
Johannesburg 88
Nanchang 88
Hebei 87
Brussels 86
Des Moines 86
Abeokuta 85
Toronto 84
Amsterdam 81
Medford 80
Bengaluru 79
London 79
Biên Hòa 78
Montreal 74
The Dalles 73
Bremen 72
Hải Dương 69
Zhengzhou 68
Can Tho 66
Tianjin 66
Vienna 65
Brooklyn 64
Orem 64
Mülheim 62
Falls Church 60
Jakarta 59
Falkenstein 58
San Francisco 58
Hyderabad 57
Olalla 56
Hangzhou 53
Nuremberg 53
Thái Nguyên 52
Atlanta 51
Bangkok 50
Totale 44.385
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.644
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 655
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 505
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 438
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 393
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 375
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 374
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 357
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 354
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 336
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 335
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 333
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 330
A comprehensive analysis on expected years of life lost due to pancreatic cancer 313
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 303
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 285
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 281
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 280
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 273
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 271
A new liver transplant priority for patients with hepatocellular carcinoma. 269
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 266
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 266
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 266
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 263
Burnout and psychological distress between surgical and non-surgical residents 259
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 255
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 251
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 250
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 248
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 245
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 243
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 241
Surgical therapy for hepatolithiasis: a Western experience. 241
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 239
Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study) 238
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 237
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 235
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 235
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 230
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 229
The peculiar aging of human liver: A geroscience perspective within transplant context 229
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 229
LncRNAs as novel players in hepatocellular carcinoma recurrence 228
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
Bacterial translocation in adult small bowel transplantation 224
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 223
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study 222
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 221
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 220
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 220
Complex Liver Transplantation Using Venovenous Bypass With an Atypical Placement of the Portal Vein Cannula 220
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 219
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 218
Acute cellular rejection monitoring after interstinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. 218
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 218
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 218
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 217
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 216
Combined liver–dual kidney transplant: Role in expanded donors 216
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 216
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 215
Coping strategies in intestinal transplantation 214
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 213
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 213
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 213
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 212
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 210
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 210
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 208
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 208
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 208
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 207
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 206
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 206
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 204
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 203
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 202
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 201
Impact of psychosocial status on liver transplant process 201
Combined heart-liver transplantation: A single-center experience 200
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 200
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 198
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 197
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 197
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 197
Efficacy of MELD score in predicting survival after liver retransplantation. 196
In Reply 196
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 195
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 194
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 194
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 193
An uncommon focal liver lesion: Intrahepatic splenosis 193
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 192
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. 191
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 191
Totale 26.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.037 0 236 357 521 587 282 163 502 298 404 1.600 1.087
2022/20237.536 720 1.097 384 968 501 610 233 488 1.339 205 574 417
2023/20242.293 195 403 149 215 178 384 108 146 89 175 133 118
2024/20259.932 481 1.357 848 760 1.362 543 713 339 226 788 577 1.938
2025/202628.205 2.150 2.633 2.245 1.741 2.489 2.542 3.586 874 5.113 2.067 1.388 1.377
2026/20271.470 668 802 0 0 0 0 0 0 0 0 0 0
Totale 71.564